May 12, 2023 Experience GSK exclusive licensing agreement with Scynexis We advised GSK on the transaction
May 3, 2023 Experience Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen We are advising Cellular Biomedicine Group on the transaction
February 24, 2021 Experience Reckitt Benckiser Group acquisition of Biofreeze We are advising RB on the acquisition
September 22, 2017 Experience Zai Lab Limited Initial Public Offering and NASDAQ Listing Davis Polk advised the joint book-running managers and representatives of the underwriters on the $172.5 million initial public offering by Zai Lab Limited of 9,583,333 American…